Mediven proudly participated in Medlab Asia & Asia Health 2023, held in Bangkok, Thailand, one of the region’s largest and most influential platforms for medical laboratory and healthcare innovations. The event brought together global healthcare leaders, laboratory professionals, and technology providers across Asia and beyond.
Our presence at the exhibition reaffirmed Mediven’s role as a forward-thinking diagnostics company, with a strong portfolio designed to meet the demands of modern healthcare systems.
Showcased Highlights from Mediven
1. ProDetect® Rapid Test Kits
A flagship product line, ProDetect® continues to impress with its fast, reliable, and easy-to-use rapid diagnostics. At the event, our test kits for COVID-19, Influenza, and Drugs of Abuse (DOA) were especially well-received. Visitors appreciated the kits’ clinical-grade accuracy and convenience, ideal for point-of-care testing in hospitals, clinics, and field applications.
2. GenoAmp® Molecular Diagnostics
Our GenoAmp® platform garnered strong attention for its high-sensitivity real-time PCR technology and multiplexing capabilities, allowing detection of multiple pathogens in a single run. Its efficiency, flexibility, and robust performance continue to position GenoAmp® as a go-to solution for laboratories aiming to streamline molecular diagnostics.
3. UBREATH FeNO Monitor
Also showcased was the UBREATH FeNO device, a non-invasive breath test for assessing airway inflammation, especially in asthma management. Its quick, painless, and portable design makes it a valuable tool for pulmonologists, general practitioners, and respiratory clinics looking to improve diagnostic precision and treatment monitoring.
4. Blood Glucose Monitoring (BGM) System
Mediven also featured its Blood Glucose Monitoring system, developed to support accurate, affordable, and easy diabetes self-management. The device’s user-friendly interface, fast readings, and cost-effective design make it a practical solution for both patients and healthcare providers in managing diabetes at home or in clinical settings.
Strengthening Regional Partnerships
Our booth attracted strong engagement from healthcare professionals, procurement teams, and potential partners across ASEAN countries. Mediven’s growing reputation for quality, innovation, and reliability continues to open new doors for collaborations in diagnostics, chronic disease management, and respiratory health. Medlab Asia 2023 marked another milestone in Mediven’s journey to becoming a trusted regional leader in diagnostics and healthcare innovation. We extend our thanks to the Mediven team and partners who made this a successful showcase of our brand and mission.
